Pulmonary hypertension occurs in rheumatologic diseases, normally as a consequence of diffuse lung disease. In scleroderma it can occur as primary hypertension without diffuse lung disease and is ...
Results: Five hundred seventy-nine patients were studied, 205 with PPH and 374 with pulmonary hypertension from other causes (secondary pulmonary hypertension [SPH]). The use of anorexigens was ...
Treatment options can vary depending on the type of pulmonary hypertension you have. Pulmonary arterial hypertension causes the small lung arteries to become narrow, stiff, or thickened. PAH is often ...
As the rollout of its recently launched pulmonary arterial hypertension (PAH) drug Winrevair ramps up, Merck is continuing its work to improve awareness of and education around the rare disease.